Filters

Experiments

Compound Investigated event Experiment type Concentration Cell line Organism Animal model Stat protein Details
Momelotinib (CYT387) Influence on cell proliferation MTS 1.00 µM DLBCL primary cells Canis familriaris patient 1
Momelotinib (CYT387) Influence on cell proliferation MTS 2.00 µM DLBCL primary cells Canis familriaris patient 1
Momelotinib (CYT387) Influence on cell proliferation MTS 3.00 µM DLBCL primary cells Canis familriaris patient 1
Momelotinib (CYT387) Influence on cell proliferation MTS 4.00 µM DLBCL primary cells Canis familriaris patient 1
Momelotinib (CYT387) Influence on cell proliferation MTS 5.00 µM DLBCL primary cells Canis familriaris patient 1
Momelotinib (CYT387) Influence on cell proliferation MTS 1.00 µM DLBCL primary cells Canis familriaris patient 2
Momelotinib (CYT387) Influence on cell proliferation MTS 2.00 µM DLBCL primary cells Canis familriaris patient 2
Momelotinib (CYT387) Influence on cell proliferation MTS 3.00 µM DLBCL primary cells Canis familriaris patient 2
Momelotinib (CYT387) Influence on cell proliferation MTS 4.00 µM DLBCL primary cells Canis familriaris patient 2
Momelotinib (CYT387) Influence on cell proliferation MTS 5.00 µM DLBCL primary cells Canis familriaris patient 2
Momelotinib (CYT387) Influence on cell proliferation MTS 1.00 µM DLBCL primary cells Canis familriaris patient 3
Momelotinib (CYT387) Influence on cell proliferation MTS 2.00 µM DLBCL primary cells Canis familriaris patient 3
Momelotinib (CYT387) Influence on cell proliferation MTS 3.00 µM DLBCL primary cells Canis familriaris patient 3
Momelotinib (CYT387) Influence on cell proliferation MTS 4.00 µM DLBCL primary cells Canis familriaris patient 3
Momelotinib (CYT387) Influence on cell proliferation MTS 5.00 µM DLBCL primary cells Canis familriaris patient 3